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Introduction
Approximately 55-70% of paediatric subjects with acquired CNS demyelination will experience a monophasic illness without clinical or radiological evidence of further disease, while up to 30% will be diagnosed with multiple sclerosis (Mikaeloff et al., 2004; Banwell et al., 2011; Langer-Gould et al., 2011) . MRI provides a window into the temporal and spatial dynamics of demyelination, and assists in distinguishing individuals destined for a monophasic illness from those for whom acquired demyelinating syndrome (ADS) is the first clinical manifestation of multiple sclerosis. In paediatric populations, the presence of both one or more T 1 -hypointense lesions, and one or more periventricular lesions at ADS onset, strongly predicts subsequent confirmation of a diagnosis of multiple sclerosis (Verhey et al., 2011 (Verhey et al., , 2013 .
MRI is a powerful tool to interrogate brain tissue integrity, both in the context of disease and in normal maturation. Diffusion tensor imaging (DTI) allows a non-invasive assessment of axonal structure and myelin status by measuring the diffusion of water molecules in brain structures (Basser and Pierpaoli, 1996) . Fractional anisotropy quantifies the preference for diffusion in one direction, and correlates with axonal diameter, density, and fibre orientation. Mean diffusivity measures mean water molecular motion, and is generally considered a marker of microstructural tissue integrity (Sen and Basser, 2005) . Diffusion properties change during typical brain development, with increasing white matter fractional anisotropy and decreasing mean diffusivity until the third or fourth decade of life (Beaulieu, 2002; Kochunov et al., 2012; Wang et al., 2012; Paus et al., 2014) . During maturation, increases in fractional anisotropy due to increasing axonal size and a more efficient axonal transport system are associated with corresponding mean diffusivity reductions due to increased restriction in cross-fibre diffusivity by increased myelination and more densely packed axons (Beaulieu, 2002; Ben Bashat et al., 2005; Gao et al., 2009; Paus et al., 2014) . As such, interpretation of DTI studies in children requires consideration of the effects of age, which influences DTI measures, and longitudinal studies require knowledge of expected developmental change.
The onset of multiple sclerosis during childhood has the potential to result in focal tissue damage (lesions), influence regional tissue integrity, and to impact normal white matter maturation. Recent cross-sectional DTI studies have described abnormalities of normal-appearing white matter (NAWM) in paediatric-onset multiple sclerosis, emphasizing that visible white matter lesions do not capture the full extent of tissue abnormality (Vishwas et al., 2010 (Vishwas et al., , 2013 Bethune et al., 2011; Till et al., 2011; Tillema et al., 2012; Aliotta et al., 2014; Rocca et al., 2014; Akbar et al., 2016) . Conceptually, the more global tissue disruption in multiple sclerosis may represent part of a subclinical continuum of chronic CNS-directed immune and degenerative processes. Whether such processes influence developmental changes in myelinating pathways is not yet known.
Children with monophasic ADS, on the other hand, experience an acute but transient insult to the CNS. While focal tissue disruption would be expected to alter regional DTI metrics, a more global insult to normalappearing tissues would not be anticipated. The impact of monophasic ADS on subsequent white matter development is unknown. Conceivably, focal damage could influence regional development, although tissue repair following monophasic inflammation may mitigate such an impact.
We performed serial imaging in children with multiple sclerosis, children with monophasic demyelination, and healthy children, and compared the temporal trajectories of NAWM DTI parameters between groups.
Materials and methods

Participants
We included children and adolescents enrolled at the Hospital for Sick Children (SickKids) with incident demyelination in the prospective Canadian Pediatric Acquired Demyelinating Disease Study or in a separate longitudinal cognitive and MRI study of paediatric subjects with established relapsingremitting multiple sclerosis Till et al., 2012) . Participants from the prospective incident cohort were enrolled at the time of clinical presentation (ADS), and were imaged as close to the time of incident demyelination as practical, and subsequently at 3, 6, and 12 months, then yearly afterwards. Participants for whom the initial ADS event represented the first attack of multiple sclerosis were also imaged at the time of further demyelinating episodes . The separate cohort of established longitudinallyassessed paediatric-onset multiple sclerosis participants were imaged longitudinally at varying time intervals from first attack (Till et al., 2012) . A comparison group of healthy paediatric participants was recruited from the community through local advertisement. Healthy participants were carefully screened to exclude known comorbidities or significant past medical history, and those with significant incidental brain abnormalities on MRI were excluded from the study. Participants were included if they had at least one DTI scan that passed quality assurance. A small number of participants with ADS and 67% of the healthy participants had DTI measurements from only a single time point. However, as we used statistical models that support a mixture of longitudinal and cross-sectional observations (see 'Statistical analysis' section), these single time point data were included in the analysis.
Participants with ADS were classified as having relapsingremitting multiple sclerosis according to the 2005 McDonald criteria (Polman et al., 2005) , as per the analytical plan devised at study onset, and as having monophasic ADS if they had no clinical or MRI evidence of new inflammatory CNS activity following incident ADS. None of the monophasic ADS participants met criteria for multiple sclerosis according to the 2010 McDonald criteria (Polman et al., 2011) . All selected participants were observed for a minimum of 3.5 years post-ADS presentation.
According to the clinical features of the initial demyelinating episode, monophasic ADS participants were further subcategorized into: (i) acute disseminated encephalomyelitis (ADEM) (defined by polyfocal neurologic deficits in a child with encephalopathy or depressed level of consciousness (Krupp et al., 2013) ; (ii) polyfocal monophasic ADS (syndromes characterized by symptoms referable to more than one area of the CNS, in the absence of any impairment in level of consciousness or encephalopathy); and (iii) monofocal monophasic ADS (deficits localized to a single CNS location, e.g. optic neuritis, transverse myelitis and brainstem syndromes). According to the appearance on the brain MRI scan at presentation, participants with monophasic ADS other than ADEM were also classified as: (i) participants with T 2 -weighted brain lesions; and (ii) participants without any brain lesion (typically children with monophasic transverse myelitis or optic neuritis).
Exclusion criteria were a history of (i) other neurological conditions; (ii) major medical comorbidities; (iii) major psychiatric comorbidity; (iv) learning disability; (v) major head injury; or (vi) alcohol or illicit drug abuse.
Institutional Research Ethics Board approval and written informed consent from each participant and/or their guardian was obtained prior to study initiation.
MRI data acquisition
All participants were scanned on a single 1.5 T GE Signa Excite MRI scanner (General Electric Healthcare) at SickKids, according to a standardized protocol including: (i) an axial dual-echo proton density/T 2 -weighted fast spin-echo sequence [1 Â 1 Â 2 mm; repetition time = 3500 ms; echo time 1/echo time 2 = 15/63 ms; echo train length = 8]; (ii) a sagittal T 1 -weighted, 3D spoiled gradient recalled echo sequence [1.5 Â 1 Â 1 mm; repetition time = 22 ms; echo time = 8 ms; flip angle = 30 ]; (iii) an axial 2D multi-slice turbo FLAIR sequence (1 Â 1 Â 5 mm; repetition time = 9000 ms; echo time = 100 ms; inversion time = 2250 ms); and (iv) a diffusion-weighted acquisition using a single shot spin-echo sequence with an echo planar imaging readout (2 Â 2 Â 5 mm, repetition time = 8300 ms, echo time = 84 ms), with one nondiffusion-weighted image (b = 0) and diffusion gradients applied in 25 non-collinear directions (b = 1000 s/mm 2 ).
MRI data analysis
All the analyses were performed at the McConnell Brain Imaging Centre, Montreal Neurological Institute (Montreal, QC, Canada). MRI scans acquired within 30 days of intravenous methylprednisolone treatment for acute relapse (n = 16) were excluded from this analysis.
Preprocessing
Images were corrected for intensity non-uniformity using N3 (Sled et al., 1998) . Non-brain tissue was removed using the Brain Extraction Tool (BET) (Smith et al., 2002) (FSLv4.1.7;  http:// www.fmrib.ox.ac.uk/fsl/). Anatomical images for each time point were registered to the T 2 -weighted image using a rigid six-parameter transformation (minctracc, MINC Toolkit). The T 2 -weighted images for each subject were registered to the MNI152 template using first a 12 parameter affine, then a non-linear transformation (minctracc, MINC Toolkit).
Tissue segmentation
NAWM, grey matter and CSF probability maps were generated using a Bayesian classifier based on atlas-based prior probabilities and voxel-wise intensity on T 1 -, T 2 -, proton density-weighted and FLAIR images. NAWM probability maps were transformed into the native space of the diffusionweighted images and thresholded at a value of 90%. The resulting NAWM masks include tissue that is relatively free of misclassification and partial volume effect, particularly that caused by the lower resolution of the diffusion-weighted images. NAWM masks for each subject were then transformed to standard space (Fonov et al., 2009 (Fonov et al., , 2011 . For subjects who had two or more research MRI scans, a logical AND operation on the serial masks was used to create subject-specific masks indicating tissue that was confidently and consistently identified as NAWM at all time points ['high confidence' NAWM ( hc NAWM)]. For subjects with ADS, supratentorial T 2 -weighted lesions were segmented using a multi-modal, intensity-based, naïve Bayesian classifier (Francis, 2004) . The automatically segmented lesions were then reviewed and manually corrected, if necessary, by trained personnel with expertise in multiple sclerosis lesion identification. New T 2 -hyperintense lesions on serial images of paediatric-onset multiple sclerosis participants were identified using an automatic change detection algorithm that classifies tissue using changes in serial T 1 -, T 2 -, proton density-weighted and FLAIR images. The method uses a two-stage classification process: candidate lesion voxels are identified by a Bayesian classifier, then contiguous sets of voxels are accepted or rejected as representing a new lesion by a random forest classifier, based on lesion-level features (Elliott et al., 2013) . Lesion masks at each time point were superimposed on the subject specific common hc NAWM mask, to ensure that no lesional tissue would be erroneously identified as NAWM.
Diffusion tensor MRI preprocessing
Eddy current-induced distortions and head motion between the diffusion weighted images were corrected using the Eddy Current Correction tool (Jenkinson and Smith, 2001 ) from the FMRIB's Diffusion Toolbox (FDT) in the FMRIB Software Library (FSL; FSL v4.1.7; http://www.fmrib. ox.ac.uk/fsl/). The diffusion tensor and its features (eigenvalues, fractional anisotropy, and mean diffusivity) were estimated at each voxel by using the dtifit utility in FSL. To allow for spatial analysis over multiple subjects and time points, each subject/time point's b0 image was non-linearly registered to the T 2 -weighted image (Avants et al., 2008) , removing susceptibility-induced fields in echo-planar DTI images, followed by a non-linear registration of the T 2 -weighted image to the MNI152 stereotaxic space. Mean fractional anisotropy and mean diffusivity values were computed at every time point within the subject-specific common hc NAWM mask. These data were compiled into fractional anisotropy and mean diffusivity time courses for each subject. Rigorous quality control was performed by trained staff after each processing step.
Study hypotheses
First, we tested the hypotheses that (i) DTI metrics in NAWM differ between paediatric-onset participants with multiple sclerosis and those with monophasic ADS; and (ii) when compared with healthy participants, longitudinal changes in DTI indicating failure of normal development of white matter will be more evident in participants with paediatric-onset multiple sclerosis. We also assessed the impact of the different monophasic CNS demyelinating syndromes on white matter development. Paediatric-onset multiple sclerosis participants were compared to children with ADEM, polyfocal monophasic ADS, monofocal monophasic ADS, and healthy participants. We expected a less severe white matter injury in ADEM compared to multiple sclerosis and other monophasic ADS, based on the common observation of very rapid resolution of T 2 -hyperintense lesions in children with ADEM. Third, since the presence of one or more parenchymal brain lesions increases the risk of multiple sclerosis outcome in participants with non-ADEM presentations , we hypothesized that non-ADEM monophasic ADS participants with brain lesions would show (i) different NAWM DTI metrics compared to non-ADEM monophasic ADS participants without brain lesions; and (ii) that longitudinal changes in DTI metrics in monophasic ADS participants with brain lesions would be more similar to those of paediatric-onset multiple sclerosis participants, while monophasic ADS with no brain lesions would more closely follow the age-expected DTI changes of the healthy participant group. Sex was included as an effect in each of the above analyses to evaluate the possible differential changes of diffusion metrics between male and female participants for each study group. Finally, we hypothesized that fractional anisotropy and mean diffusivity changes would be influenced by the extent of macroscopic lesion load, and we explored the effects of T 2 -weighted lesion volume at onset on NAWM DTI metrics of monophasic ADS and multiple sclerosis participants over time. To investigate the potential effects of axonal degenerative phenomena after ADS versus chronic disruption of normal development, we also performed additional separate analyses for measurements obtained in the first 2 years from ADS ('early-only' analysis) and those obtained from the second year onward ('lateonly' analysis).
Statistical analysis
Fractional anisotropy and mean diffusivity time courses were analysed using general linear mixed models, and identical models were fit to each of (i) all the available data; (ii) measurements taken less than 2 years after ADS (early-only); and (iii) measurements from more than 2 years after ADS (lateonly). The statistical analyses were performed using custom software (Brown et al., 2014) written in Python (Python Software Foundation, python.org) and R (R Core Team, 2010) using the Scientific Python package (Scipy, www.scipy. org), the RPy2 module (RPy2, rpy.sourceforge.net) and the lme4 package (Bates et al., 2011) .
Fractional anisotropy and mean diffusivity time courses were modelled using the lme4 equation:
where sex, ageAtADS, the interaction between diagnosis (monophasic ADS, paediatric-onset multiple sclerosis, healthy participants) and timeFromADS, and the interaction between sex, diagnosis, and timeFromADS were fixed effects; (1|sub-ject) provided a subject-specific random intercept, allowing for correlation among multiple measurements from the same subject over time. Equations 1 and 2 model fractional anisotropy and mean diffusivity from the time of clinical presentation (timeFromADS = 0) onward. Note that subject age at the time of scan is equal to ageAtADS + timeFromADS; rather than modelling these as a unified age term, which postulates a single rate of change in fractional anisotropy and mean diffusivity since birth, our model begins with an age-adjusted intercept at clinical presentation. In the healthy participants, for whom ageAtADS is set to zero, the term timeFromADS represents the effect of simple age on fractional anisotropy and mean diffusivity; that is, healthy participants are modelled as having a single trajectory, while other groups are allowed to have an inflection point (or change of trajectory) at the time of ADS (ageAtADS). From ageAtADS in the multiple sclerosis and monophasic ADS groups, fractional anisotropy and mean diffusivity change over time at a disease-specific rate, given by the diagnosis:timeFromADS term. This rate of change will capture the combined effects of ongoing developmental and disease processes. Sex was coded as 0 for females and 1 for males, so terms that do not include sex indicate the expected effect in females. Terms that do include sex represent additional effects, if any, in males, relative to females.
The log-likelihoods of each model were compared to those of a null model, with no fixed effects, using 2 tests. This 'gateway test,' which is similar to that used in ANOVA, indicates whether the model as a whole has significant explanatory power. Analysis proceeds only if it is significant. The significance of individual fixed effects was tested using f-tests, with the denominator degrees of freedom estimated using a Satterthwaite approximation from the R package MixMod (Kuznetsova and Brockhoff, 2012) . As these subtests are only performed if the gateway test is significant, they do not need to be corrected for multiple comparisons. R 2 values for the models were calculated according to the procedures suggested by Nakagawa and Schielzeth (2013) : the marginal R 2 is the proportion of the variance explained by the fixed effects alone, and the conditional R 2 is the variance explained by the entire model, including the random effects (Nakagawa and Schielzeth, 2013) .
If the preceding models (Equations 1 and 2) showed a significant diagnosis:timeFromADS interaction, indicating a difference in fractional anisotropy and mean diffusivity time courses between participant groups, a subanalysis was performed using the following models: where presentation indicates the clinical phenotype at presentation (healthy participant, ADEM, monofocal monophasic ADS, polyfocal monophasic ADS or paediatric-onset multiple sclerosis) and lesionGroup is one of healthy participant, paediatric-onset multiple sclerosis, non-ADEM monophasic ADS with brain lesions or non-ADEM monophasic ADS without brain lesions.
For each model, if an effect of interest was found to be significant, the significance of individual levels of each categorical variable (diagnosis, presentation, lesionGroup and sex) was evaluated using t-tests on the appropriate contrasts. For all models, female healthy participants formed the reference group; any terms that do not contain an interaction with sex are for females, and those that do not contain an interaction with diagnosis are for healthy participants. Female participants in the multiple sclerosis and monophasic ADS groups were compared to each other and to female healthy participants. The same was done for the males, however, male versus male comparisons in the diagnosis, presentation and lesion group models were performed only if significant differences were observed between males and females within the same group, and results are provided in tables if significant. For example, the contrast:
tests whether female paediatric-onset multiple sclerosis and female healthy control participants experience different changes in NAWM over time; the contrast:
in the fractional anisotropy model indicates whether the rate of change of fractional anisotropy in female paediatric-onset multiple sclerosis is significantly different from zero; whereas the contrast: sexM:diagnosis MS :timeFromADS ¼ 0 tests whether the rate of change in male participants with paediatric-onset multiple sclerosis is significantly different from that of female participants with paediatric-onset multiple sclerosis. In the tables, the contrasts are written using a condensed notation (see Table 3 legend for explanation).
Finally, the effect of T 2 -weighted lesion volume on fractional anisotropy and mean diffusivity of participants with demyelinating syndromes was evaluated by extending Equations 1 and 2 by adding interactions with lesionVolume: 
Results
Overall, 611 scans from 212 participants were included in the analysis. The demographic characteristics of the participants are displayed in Table 1 . Some of the paediatric-onset multiple sclerosis participants received disease-modifying treatment for the whole or part of the study follow-up (glatiramer acetate, n = 15, 38/611 scans, interferon b-1a, n = 19, 42/611 scans; interferon b-1b, n = 5, 15/611 scans or fingolimod, n = 1, 1/611 scans). One paediatric-onset multiple sclerosis participant was exposed to cyclophosphamide (2/611 scans).
Results of the statistical analysis are summarized qualitatively in Table 2 and detailed in Table 3 . Supplementary material provides results for the early-only and chroniconly subanalyses. For multi-level categorical variables, if the relevant test in the model was significant, contrasts on individual levels were performed and are provided in the corresponding tables.
Effect of age on NAWM of paediatric healthy participants
Fractional anisotropy increased and mean diffusivity decreased with age in healthy participants, as is expected in normal development. Sex-time interactions were not significant in the healthy participant group for either fractional anisotropy or mean diffusivity overall. Region-specific developmental differences in DTI metrics between males and females during childhood and adolescence have been described (Schmithorst et al., 2008; Asato et al., 2010; Bava et al., 2011) , but other whole-brain white matter analyses have been insensitive to these differences (Hasan et al., 2007) .
Differences in longitudinal NAWM changes between monophasic ADS and paediatric-onset multiple sclerosis participants NAWM fractional anisotropy and mean diffusivity trajectories in the paediatric-onset multiple sclerosis group were significantly different from those of healthy paediatric 14.9 (6.1-23.9) 12.3 (4.6-16.8) 10.0 (2.3-15.9) 11.3 (4.0-15.9) 10.6 (5.9-15.8) 10.9 (4.0-15.9) 11.6 (5.9-15.8) 6.5 (2.3-13.6) Mean clinical follow-up, years (range) -7.7 (1.7-19.2) 5.8 (2.1-9.0) 5.8 (2.1-9.0) 6.0 (2.7-8.8) 5.9 (2.1-9.0) 5.6 (3.0-8.7) 5. 6 (2.3-8.9)
Mean radiological follow-up, years (range) 'Clinical follow-up' refers to the elapsed time between the onset of first clinical symptoms and the most recent assessment; 'radiological follow-up' refers to the elapsed time between the first and last DTI scan analysed; 'mean time to DTI' refers to the time from ADS to the first available DTI that passed quality control; 'lesion-negative' and 'lesion-positive' refer to the absence or presence of brain T 2 -hyperintense lesions at the time of the first available research MRI scan post-ADS. HP = healthy participants. Where zero is entered as the smallest range value, it refers to subjects for whom only one DTI time point was used for the purposes of this analysis (3/58 multiple sclerosis subjects, 3/74 monophasic ADS, and 54/80 healthy participants). 26/80 healthy participants (33%) had longitudinal MRI data (two time points).
g Two pediatric-onset multiple sclerosis patients presented with bilateral optic neuritis or transverse myelitis had no lesions extrinsic to the site responsible for the acute symptoms on the first research MRI scan post-ADS. They demonstrated brain lesion accrual over time, and fulfilled the diagnostic criteria for multiple sclerosis (Polman et al., 2005; Krupp et al., 2013) . participants, in directions opposite to those expected for normal white matter development (decreasing fractional anisotropy and increasing mean diffusivity) (Fig. 1 , Tables 2  and 3 ). Fractional anisotropy was not found to exhibit a significant sex-diagnosis-time interaction effect (Equation 1). This interaction was significant for Equation 2, revealing different mean diffusivity trajectories between male and female participants in the paediatric-onset multiple sclerosis group, where females showed an increase of mean diffusivity over time, and males did not show any significant change of longitudinal mean diffusivity. Both trajectories were significantly abnormal compared to that of the healthy paediatric participants. These results suggest both failure of age-expected development and loss of existing tissue integrity in the paediatric-onset multiple sclerosis group. Differences in mean diffusivity trajectories between male and female participants may suggest a potential sexual dimorphism in multiple sclerosis-related effects on NAWM microstructure. Fractional anisotropy did not significantly change over time in monophasic ADS participants, but its trajectory differed from that of participants with paediatric-onset multiple sclerosis. Likewise, mean diffusivity did not significantly change in monophasic ADS participants, but its trajectory in both males and females differed from that of females with paediatric-onset multiple sclerosis; the comparison between males with monophasic ADS and males with multiple sclerosis did not reach statistical significance. This suggests a better preservation of NAWM development in monophasic ADS participants compared to the paediatric-onset multiple sclerosis group. However, even though fractional anisotropy and mean diffusivity did not change over time in the monophasic ADS group, and thus may not follow age-expected changes, the effect of monophasic ADS did not reach significance versus healthy participants.
Fractional anisotropy and mean diffusivity time courses for the early-only and late-only analyses (Supplementary Fig. 1 and Supplementary Table 1) were similar to the analysis of all time points, although differences in mean diffusivity trajectories in male and female participants were noted in the chronic phases: in all groups, males experienced greater mean diffusivity decline than females. The results of the early-and late-only analyses confirm in the paediatric-onset multiple sclerosis group a progressive failure of age-expected development and loss of tissue integrity, already present in the first years after diagnosis and persisting over time. The early-only and late-only analyses suggest non-significant deficits of similar magnitude in fractional anisotropy development in the monophasic ADS group versus healthy participants.
Differences in longitudinal NAWM changes between the different monophasic ADS clinical phenotypes
There was no sex-presentation-time interaction effect on fractional anisotropy (Equation 3) but, as further detailed below, there was for mean diffusivity (Equation 4).
We did not detect significant changes in either fractional anisotropy or mean diffusivity over time in female participants with ADEM, or in monofocal or polyfocal monophasic ADS participants of either sex (Fig 2, Tables 2 and 3 ). As fractional anisotropy and mean diffusivity of NAWM are expected to change (increase and decrease, respectively) with normal brain development, this again may suggest a perturbation of normal white matter development, especially in the female participants with ADEM, in whom the rate of change of mean diffusivity differed significantly from that of female healthy participants. Interestingly, fractional anisotropy trajectories of participants of both sexes and the mean diffusivity trajectory of female participants with ADEM did not significantly differ from those of paediatric-onset multiple sclerosis. However, male participants with ADEM experienced a decrease of mean diffusivity 
" or # Indicates a significant increase or decrease, respectively, over time. ! Indicates a slope that is not significantly different from zero. 6 ¼ Indicates a trajectory that is significantly different from that of pediatric healthy participants. F = females; M = males (for analyses that demonstrated significant sexual dimorphism). FA = fractional anisotropy; MD = mean diffusivity. with time, with a significantly different trajectory from that of female participants. Monofocal monophasic ADS participants displayed better preservation of NAWM trajectories than the other groups, with fractional anisotropy and mean diffusivity trajectories that differed significantly from those of paediatriconset multiple sclerosis but not from those of paediatric healthy participants.
The analysis of early-only and late-only measurements ( Supplementary Fig. 2 and Supplementary Table 2) provided overall results similar to those provided by the analysis of all time points. However, the chronic-only model revealed even more pronounced changes in participants of both sexes with ADEM, in whom the trajectory of fractional anisotropy and mean diffusivity became significantly different from that of both the healthy paediatric and monofocal monophasic ADS groups. Of note, as opposed to the early phase in which male and female participants with ADEM showed different mean diffusivity trajectories (with females having a faster, and significantly abnormal, rate of mean diffusivity increase), no significant sex-presentation-time interaction effect was detected at later time points within this group.
Differences in longitudinal NAWM changes between monophasic ADS with and without brain lesions
There were no sex-group-time interaction effects on either fractional anisotropy or mean diffusivity trajectories (Equations 5 and 6) (Fig. 3, Tables 2 and 3 ). Post-presentation NAWM fractional anisotropy decreased over time in non-ADEM monophasic ADS participants with The random effect (1 | subject) was significant for all models at P 5 10
À5
. Estimates and their standard errors are expressed in scalar values between 0 and 1 / year for fractional anisotropy, and in m 2 Â s À1 Â 10 À9 / year for mean diffusivity. For clarity, contrasts are given using a condensed notation; for example, the interaction Disease monoADS : timeFromADS is abbreviated 'monoADS : timeFromADS'; the term Sex(M) is abbreviated 'M'. FA = fractional anisotropy; MD = mean diffusivity; HP = healthy participants. parenchymal brain lesions. These participants displayed worse NAWM fractional anisotropy trajectories than either healthy participants or non-ADEM monophasic ADS participants with a normal parenchymal brain MRI, and were not significantly different from those of paediatric-onset multiple sclerosis participants. The post-presentation NAWM fractional anisotropy of non-ADEM monophasic ADS participants with normal brain MRI did not change significantly over time. Despite the absence of the age-expected fractional anisotropy increases, this trajectory was not significantly Figure 1 Evolution of NAWM fractional anisotropy (A) and mean diffusivity (B) in paediatric-onset multiple sclerosis, monophasic ADS, and healthy participants. Points connected by light lines are individual participants. Heavy lines show trajectories predicted by the model for each study group, with age at onset set at 5 years (zero for healthy participants). In the figures, solid lines indicate trajectories in females. Where significant differences between females and males were found, dashed lines of the same colour indicate the trajectory in males. Uniformly coloured circles indicate that the group trajectory is significantly different from zero, while circles with differently coloured hemispheres indicate a significant difference between the corresponding two groups. While the healthy participant group shows expected maturational trajectories (increasing fractional anisotropy and decreasing mean diffusivity over time), the monophasic ADS group does not present significant NAWM diffusion changes, and their mean trajectories are intermediate between those of the healthy participant and paediatric-onset multiple sclerosis groups. While fractional anisotropy trajectories in paediatric-onset multiple sclerosis are not significantly different between sexes, males appear to have a slower rate of mean diffusivity increase than females (F). Shaded areas are 95% confidence intervals. Fractional anisotropy is expressed in scalar values between 0 and 1. Mean diffusivity in m 2 Â s À1 Â 10
À9
. Figure 2 Evolution of NAWM fractional anisotropy (A) and mean diffusivity (B) in paediatric-onset multiple sclerosis, different clinical presentations of monophasic ADS, and healthy participants. Monophasic ADS participants presenting with ADEM show a fractional anisotropy trajectory that is intermediate between paediatric healthy participants and paediatric-onset multiple sclerosis, and not significantly different than either. Females with ADEM show significantly abnormal mean diffusivity trajectories compared to males with ADEM and healthy participants. Further analysis of the late phases (42 years) after clinical presentation revealed significant abnormal NAWM fractional anisotropy and mean diffusivity trajectories in the ADEM participants ( Supplementary Fig. 5 ). Longitudinal fractional anisotropy and mean diffusivity of monofocal monophasic ADS participants of both sexes differed from that of paediatric-onset multiple sclerosis, and more closely approximated the trajectories seen in the healthy participants, indicating a more normal developmental trajectory. F = female; M = male.
abnormal compared to that of the healthy paediatric participants. NAWM mean diffusivity did not vary significantly over time in non-ADEM monophasic ADS participants with or without brain lesions. Paediatric-onset multiple sclerosis participants displayed a faster increase in NAWM mean diffusivity than lesion-negative monophasic ADS participants, but this difference was not significant versus lesionpositive monophasic ADS.
Interestingly, the early-only analysis did not reveal any significant differences in fractional anisotropy trajectories between non-ADEM monophasic ADS participants with and without parenchymal brain lesions, or between non-ADEM monophasic ADS participants with brain lesions and paediatric healthy participants. These differences became significant in the analysis of late time points, which also revealed significantly abnormal mean diffusivity trajectories in non-ADEM monophasic ADS participants with brain lesions compared to either paediatric healthy participants and non-ADEM monophasic ADS participants without brain lesions ( Supplementary Fig. 3 and Supplementary Table 3) .
Effect of T 2 -weighted lesion volume
No significant diagnosis-specific effects of supratentorial parenchymal brain lesion volume on average fractional anisotropy or mean diffusivity or their trajectories were observed in the analysis of all time points (Table 3) . However, a paediatriconset multiple sclerosis-specific effect of lesion volume on fractional anisotropy and mean diffusivity reached significance in the early phase, suggesting that increased lesion volume is associated with lower average fractional anisotropy and higher average mean diffusivity in NAWM of paediatriconset multiple sclerosis, but not in monophasic ADS. In the late phase, we observed increased average fractional anisotropy in males with monophasic ADS and greater lesion volume.
The analysis of mean diffusivity revealed, in the early phase, increased average mean diffusivity in participants with paediatric-onset multiple sclerosis who had greater lesion volumes. In the late phase, within the paediatriconset multiple sclerosis group, greater lesion volume was associated with a faster rate of increase of mean diffusivity in female compared to male participants. This sex-multiple sclerosis-specific effect on mean diffusivity was also significant in the overall analysis.
Discussion
In a large prospective cohort, we show that monophasic and chronic acquired inflammatory demyelination during childhood negatively impacts tissue integrity in NAWM. DTI metrics in the NAWM of paediatric multiple sclerosis patients diverge from those in healthy participants over time, suggesting that paediatric-onset multiple sclerosis is associated with failure to achieve age-expected white matter maturation and with progressive loss of tissue integrity over time.
These findings differ, however, from those of children with monophasic demyelination. In monophasic patients, those with white matter lesions (ADEM and non-ADEM patients) have abnormal fractional anisotropy and mean diffusivity trajectories in NAWM, a finding that was not detected in monophasic patients with isolated optic nerve or spinal cord demyelination. Importantly, while there was no suggestion of progressive loss of tissue integrity, these monophasic patients failed to 'catch-up' to normal diffusivity trajectories after the second year post-ADS, indicative of both an acute and long- lasting impact of transient demyelinating illness on nonlesional white matter integrity.
Comparison with other diffusion tensor imaging studies of paediatric ADS To date, cross-sectional DTI studies in paediatric patients with multiple sclerosis and monophasic demyelination have reported variable findings. Tillema et al. (2012) reported differences in diffusion metrics in NAWM between children with established multiple sclerosis (n = 17) and healthy controls, as well as reduced fractional anisotropy and increased mean diffusivity and radial diffusivity in children with monophasic ADS imaged close to the time of acute illness. In contrast, Absinta et al. (2010) did not observe abnormalities in the NAWM in 10 children with isolated demyelination, although they did find reduced fractional anisotropy and increased diffusivity (relative to healthy controls) in the NAWM in 38 children with confirmed multiple sclerosis. Finally, Vishwas et al. (2013) evaluated 20 children with established multiple sclerosis, 27 participants with a first acute demyelinating attack, imaged within 6 months from clinical presentation (nine with clinically monofocal demyelination, nine with polyfocal symptoms, and nine with polyfocal symptoms plus encephalopathy), and 20 healthy youths. Six of 27 patients were subsequently diagnosed with multiple sclerosis. DTI parameters were not predictive of multiple sclerosis outcome in this study. Participants with paediatric multiple sclerosis showed widespread DTI abnormalities in NAWM compared to healthy controls-very similar to our findings. DTI findings in the polyfocal groups (with and without encephalopathy) were more subtle, with abnormalities in fractional anisotropy observed in only a few of the white matter tracts analysed.
We believe that our work adds to the findings of these authors in several important ways. Not only do we further confirm a diffuse abnormality in NAWM in paediatric multiple sclerosis patients, we also interpret our longitudinal results to show that multiple sclerosis onset during childhood impairs normal age-expected myelination and is associated with actual progressive tissue insult. Our findings in monophasic demyelination may help clarify the variable results of prior studies, in that we were able to show that the presence or absence of brain lesions at onset influences findings in NAWM, something that other studies were not as clearly able to evaluate. Our longitudinal analysis of children recovered from monophasic demyelination demonstrates the long-lasting impact of transient demyelination.
Diffusivity trajectories in healthy control subjects
As expected, increasing fractional anisotropy and decreasing mean diffusivity with age was found in our healthy control cohort. Although region-specific patterns of DTI changes differ between males and females during normal white matter development (Schmithorst et al., 2008; Asato et al., 2010; Bava et al., 2011) , we were not powered to explore regional white matter characteristics as a function of sex. When considering whole brain NAWM trajectories, our data are consistent with other whole-brain analyses of typical white matter development, which are insensitive to male-female differences in fractional anisotropy and mean diffusivity (Hasan et al., 2007) .
Failure of normal white matter development and progressive loss of tissue integrity in paediatric-onset multiple sclerosis Paediatric multiple sclerosis patients did not demonstrate age-expected DTI changes. Decreasing, rather than increasing fractional anisotropy occurred, and in female multiple sclerosis patients, mean diffusivity increased, rather than decreased. Reductions in NAWM fractional anisotropy have been attributed to axonal degeneration, demyelination, gliosis, a decrease of orientational coherence of fibres (Pierpaoli et al., 2001; Renoux et al., 2006; van Hecke et al., 2009; Zollinger et al., 2011; Paus et al., 2014; Pesaresi et al., 2015) , and possibly to changes in the cytoskeletal structure (Beaulieu, 2002; Paus et al., 2014; Pesaresi et al., 2015) . Increases in mean diffusivity are thought to reflect myelin degradation and decreased tissue density (Aung et al., 2013) . Thus, the combination of decreased fractional anisotropy and increased mean diffusivity in NAWM is generally considered to be an index of neurodegeneration, and more specifically in regions with specific tracts, of Wallerian degeneration (Pierpaoli et al., 2001) .
The observed differences in longitudinal mean diffusivity between males and females with paediatric-onset multiple sclerosis may indicate a milder impact on NAWM microstructure in males. This may relate to relative resistance of male adolescents to the pathological processes that subserve Wallerian degeneration (in males, axons are thicker on average and experience more rapid radial growth compared to females) (Perrin et al., 2008 (Perrin et al., , 2009 Pesaresi et al., 2015) , and possibly to differences in age-related myelin properties of developing white matter pathways, which may make male adolescents less susceptible to multiple sclerosisrelated inflammatory and neurodegenerative processes. An alternative interpretation of the decreasing fractional anisotropy in the context of stable or decreasing mean diffusivity in our male paediatric-onset multiple sclerosis participants might be that other pathological processes are at play, such as glial infiltration (Beaulieu, 2002; Burzynska et al., 2010; Giannetti et al., 2015) , or a more pronounced brain tissue 'compaction' in the context of failure of brain growth (Kerbrat et al., 2012; Aubert-Broche et al., 2014) . It is not clear why such processes would be more likely in males, however.
Diffusion tensor imaging in children with monophasic demyelination
In contrast to paediatric-onset multiple sclerosis participants, in whom the sentinel clinical attack occurs in the context of a presumed established and potentially longstanding subclinical CNS inflammatory biology, it could be hypothesized that the NAWM of monophasic ADS participants is normal at the time of ADS, might remain structurally intact, and then, in the absence of chronic disease, should continue to develop normally. Although the DTI metrics of NAWM in children with monophasic ADS as a whole were not significantly different from healthy participants, we did not see age-expected increase in fractional anisotropy and decrease in mean diffusivity, hinting that NAWM development might be perturbed. As in the paediatric-onset multiple sclerosis group, in the chronic phases, males with monophasic ADS showed less pronounced increases in NAWM mean diffusivity, further supporting possible sexual dimorphism in the effects of CNS inflammation.
The influence of white matter lesions on diffusion tensor imaging findings
As might be expected, the presence of a higher parenchymal brain T 2 lesion volume, which can be interpreted as a marker of more severe disease, had an adverse effect on NAWM diffusion metrics in the paediatric multiple sclerosis group. The complex models required for our analyses may have limited our ability to prove this relationship statistically in the analysis of all time points. However, the influence of higher T 2 lesion volumes on NAWM DTI metrics was significant in the early phases (first 2 years), in accordance with the highly inflammatory disease course in the first years from symptom onset. In our male paediatric-onset multiple sclerosis patients, and in the late phases only, we noted that a greater decrease (rather than increase) of NAWM mean diffusivity was associated with higher lesion volumes, compared to females. As discussed, this may relate to a relative resistance of male adolescents to the pathological processes that subserve Wallerian degeneration.
In the monophasic ADS patients, we first analysed the contribution of total T 2 lesion volume on DTI trajectories. We acknowledge that research scans were not always obtained at the time of ADS presentation, due to acute illness severity or young age. As such, for some of the participants, our lesion volumes have only been measured when T 2 -weighted lesions may have partially resolved. With this caveat, we found only one significant effect of T 2 -weighted lesion volume in the monophasic ADS group: in the late phases (42 years post-ADS), greater residual lesion volumes were associated with higher average fractional anisotropy in males. However, this sex-specific effect was observed only in the average fractional anisotropy, not in the fractional anisotropy trajectory, and was not accompanied by any effects on mean diffusivity, and so should be interpreted with caution. A more important relationship appeared to be whether lesions were present at all. Children with monophasic ADS in whom multifocal brain lesions were absent demonstrated DTI trajectories similar to healthy participants, while those with brain lesions did not. For those with brain lesions, the fractional anisotropy and mean diffusivity in the late analysis (42 years post-ADS) showed increasingly different fractional anisotropy and mean diffusivity values as compared to children who did not have brain lesions, and from healthy participants. As this pattern was not seen in the first 2 years post-presentation, our results suggest that, contrary to expectation, the changes in NAWM DTI metrics seen in the lesion-positive group in the analysis from all time points are driven by chronic, rather than acute changes. Whether these late NAWM changes suggest the presence of subtle ongoing disease is unknown, as none of these individuals have demonstrated any overt evidence of new lesions, clinical attacks, or features suggestive of active disease. However, inherent in any study of ADS is the possibility that ongoing longitudinal observation will confirm a diagnosis of multiple sclerosis in some of the patients currently classified as monophasic.
Children with ADEM often have very high T 2 lesion volumes at onset, over 95% of which will remain monophasic and most experience very rapid resolution of clinical and MRI evidence of brain inflammation. As such, it may be hypothesized that the T 2 -hyperintense lesions observed at ADEM onset have relatively little impact on neighbouring white matter. However, participants of both sexes with ADEM failed to show the expected increase in fractional anisotropy observed during normal white matter development, and females with ADEM also showed mean diffusivity trajectories that significantly deviated from those of healthy participants. These results were unchanged when analysing the early time points separately (52 years from presentation), in which females with ADEM also showed mean diffusivity trajectories that differed from those of children with monofocal monophasic ADS. Surprisingly, in the late time points analysis the abnormalities of fractional anisotropy trajectories reached statistical significance versus healthy participants in participants with ADEM of either sex. Moreover, although males with ADEM showed mean diffusivity trajectories more similar to those of healthy participants in the early phase after presentation, this sex-specific effect was lost in the late phase. These results will need replication, but again suggest subtle differences in the impact of CNS demyelination between males and females. ADEM typically presents at younger age than the other ADS types, when white matter undergoes faster rates of structural and functional maturation, and thus may be particularly vulnerable to insult. Our findings challenge the concept that the rapid clinical recovery and resolution of visible T 2 lesions in ADEM signify a more benign process at the tissue level.
Conclusions
Acquired demyelination of the CNS during childhood leads to disruption of NAWM, even in the context of monophasic illness. Future studies, utilizing a regional analytical approach, should explore the impact of ADS and paediatric-onset multiple sclerosis in white matter pathways with differing developmental myelination timelines. Such an approach may help to clarify whether the effect of ADS on white matter development is influenced by the region-specific maturational phase at the time of injury (ADS), whether this differs by sex, and the contribution of primary myelination to white matter development after damage.
